Skip to main content
. Author manuscript; available in PMC: 2021 Apr 23.
Published in final edited form as: Mol Cell Endocrinol. 2017 Sep 28;469:98–106. doi: 10.1016/j.mce.2017.09.032

Figure 1:

Figure 1:

MEN1 mutations in cancers

Aggregation of singular studies and TCGA analyses demonstrates that MEN1 mutations are relatively infrequent in cancers with the exception of pancreatic neuroendocrine tumors and parathyroid adenomas (cbiportal.org).